![Stefan Ericsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 28 679 $ in data 31/05/2026
Stefan Ericsson is currently Chief Financial Officer at BioInvent International AB since 2016.
Formerly, Mr. Ericsson worked as an Auditor at PricewaterhouseCoopers i Sverige AB from 1990 to 1995.
Mr. Ericsson completed an MBA at the University of Lund.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2025 | 8.000 ( 0,01% ) | 28 679 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | Direttore Finanziario/CFO | 01/01/2016 |
| Società | Posizione | Fine |
|---|---|---|
PricewaterhouseCoopers i Sverige AB
 PricewaterhouseCoopers i Sverige AB Miscellaneous Commercial ServicesCommercial Services Operates as an auditing and business advisory firm | Comptroller/Controller/Auditor | 01/01/1995 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
BioInvent International AB
 BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PricewaterhouseCoopers i Sverige AB
PricewaterhouseCoopers i Sverige AB Miscellaneous Commercial ServicesCommercial Services Operates as an auditing and business advisory firm | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
